• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病纵向认知亚型的预测模型。

A predictive model for longitudinal cognitive subtypes in Parkinson's disease.

作者信息

Wang Meng-Yun, Xin Ran, Shao Jing-Yu, Wang Sheng-Hui, Yang Hong-Qi, Zhang Hong-Ju, Zhang Jie-Wen, Chen Shuai

机构信息

Department of Neurology, Henan University People's Hospital, Zhengzhou, 450003, Henan, China.

School of Nursing, China Medical University, Shenyang, 110122, China.

出版信息

Neurol Sci. 2025 Jun;46(6):2627-2635. doi: 10.1007/s10072-024-07953-3. Epub 2025 Jan 8.

DOI:10.1007/s10072-024-07953-3
PMID:39775367
Abstract

BACKGROUND

Longitudinal cognitive changes in Parkinson's disease (PD) exhibit considerable heterogeneity.Predicting cognitive trajectories in early PD patients can improve prognostic counseling and guide clinical trials.

METHODS

This study included 337 early PD patients with 6-year follow-up in the Parkinson's Progression Markers Initiative (PPMI) database.Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) to identify subtypes of longitudinal cognitive trajectories, and a nomogram predictive model was constructed using baseline clinical variables.

RESULTS

The 337 PD patients had a mean age of 61.0 years, mean disease duration of 0.55 years, and mean MoCA score of 27.1 points. Latent class mixed models (LCMM) identified two longitudinal cognitive subtypes: cognitive stable (276 cases, 81.9%) and cognitivel deteriorating (61 cases, 18.1%). The cognitively deteriorating subtype presented poorer baseline cognition, older age, and more severe motor and non-motor symptoms. On biomarkers, the cognitively deteriorating subtype revealed higher serum NFL levels and lower mean striatum DAT uptake. Six baseline clinical variables (age, Letter Number Sequencing score, Symbol Digit Modalities Test score, Benton Judgment of Line Orientation Test score, Hopkins Verbal Learning Test-Revised score, and REM Sleep Behavior Disorder) were selected to construct the nomogram predictive model which achieved an AUC of 0.92.The calibration curve demonstrated high consistency between predicted and observed probabilities.The predictive model has potential utility in disease-modifying clinical trials by pre-screening patients at high risk for cognitive deterioration.

CONCLUSION

This study identified two longitudinal cognitive subtypes: cognitive stable and cognitive deterioration within 6-year follow-up, and eighteen percent of early PD patients shared the cognitive deterioration subtype The predictive model, incorporating six baseline variables could estimate the risk of longitudinal cognitive deterioration in PD.

摘要

背景

帕金森病(PD)的纵向认知变化表现出相当大的异质性。预测早期PD患者的认知轨迹可以改善预后咨询并指导临床试验。

方法

本研究纳入了帕金森病进展标志物倡议(PPMI)数据库中337例接受了6年随访的早期PD患者。使用蒙特利尔认知评估(MoCA)评估认知功能,以确定纵向认知轨迹的亚型,并使用基线临床变量构建列线图预测模型。

结果

337例PD患者的平均年龄为61.0岁,平均病程为0.55年,平均MoCA评分为27.1分。潜在类别混合模型(LCMM)确定了两种纵向认知亚型:认知稳定型(276例,81.9%)和认知恶化型(61例,18.1%)。认知恶化型亚型表现出较差的基线认知、年龄较大以及更严重的运动和非运动症状。在生物标志物方面,认知恶化型亚型显示血清神经丝轻链(NFL)水平较高,纹状体多巴胺转运体(DAT)摄取平均值较低。选择六个基线临床变量(年龄、字母数字序列得分、符号数字模式测试得分、本顿线方向判断测试得分、霍普金斯词语学习测试修订版得分和快速眼动睡眠行为障碍)构建列线图预测模型,其曲线下面积(AUC)为0.92。校准曲线显示预测概率与观察概率之间具有高度一致性。该预测模型通过对认知恶化高风险患者进行预筛选,在疾病修饰临床试验中具有潜在效用。

结论

本研究在6年随访中确定了两种纵向认知亚型:认知稳定型和认知恶化型,18%的早期PD患者属于认知恶化型亚型。纳入六个基线变量的预测模型可以估计PD患者纵向认知恶化的风险。

相似文献

1
A predictive model for longitudinal cognitive subtypes in Parkinson's disease.帕金森病纵向认知亚型的预测模型。
Neurol Sci. 2025 Jun;46(6):2627-2635. doi: 10.1007/s10072-024-07953-3. Epub 2025 Jan 8.
2
Disease progression subtypes of Parkinson's disease based on milestone events.基于里程碑事件的帕金森病疾病进展亚型。
J Neurol. 2024 Oct;271(10):6791-6800. doi: 10.1007/s00415-024-12645-1. Epub 2024 Aug 26.
3
Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.患有快速眼动睡眠行为障碍的早期帕金森病患者认知功能的纵向变化。
Parkinsonism Relat Disord. 2016 Jun;27:102-6. doi: 10.1016/j.parkreldis.2016.03.006. Epub 2016 Mar 12.
4
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.临床变量和生物标志物在新诊断帕金森病患者认知障碍预测中的作用:一项队列研究
Lancet Neurol. 2017 Jan;16(1):66-75. doi: 10.1016/S1474-4422(16)30328-3. Epub 2016 Nov 18.
5
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.帕金森病执行功能综合量表:一种用于在临床试验中检测认知衰退的测量工具。
Neurology. 2024 Jul 23;103(2):e209609. doi: 10.1212/WNL.0000000000209609. Epub 2024 Jun 13.
6
Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort.帕金森病患者运动进展轨迹与轻度认知障碍风险:来自 PPMI 队列的潜在类别轨迹模型。
CNS Neurosci Ther. 2024 Aug;30(8):e14918. doi: 10.1111/cns.14918.
7
Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.蒙特利尔认知评估量表、简易精神状态检查和 SCOPA-Cog 在非痴呆帕金森病患者中的变化反应性。
Dement Geriatr Cogn Disord. 2019;47(4-6):187-197. doi: 10.1159/000496454. Epub 2019 Jul 17.
8
Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1).用临床标志物预测帕金森病患者的认知能力下降(PRECODE-1)。
J Neural Transm (Vienna). 2020 Jan;127(1):51-59. doi: 10.1007/s00702-019-02125-6. Epub 2019 Dec 18.
9
Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer's disease-associated biomarkers alterations among de novo Parkinson's disease patients: a prospective cohort study.脑脊液 GFAP 是预测首发帕金森病患者向痴呆和阿尔茨海默病相关生物标志物改变转化的生物标志物:一项前瞻性队列研究。
J Neuroinflammation. 2023 Jul 20;20(1):167. doi: 10.1186/s12974-023-02843-5.
10
Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study.携带p.A53Tα-突触核蛋白的帕金森病与特发性帕金森病的运动和非运动特征:帕金森病进展标记物计划(PPMI)研究的纵向数据
J Neurol. 2025 Feb 12;272(3):203. doi: 10.1007/s00415-024-12836-w.

引用本文的文献

1
Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation.帕金森病:弥合差距、构建生物标志物及重塑临床转化
Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161.

本文引用的文献

1
Long-Term Dementia Risk in Parkinson Disease.帕金森病患者的长期痴呆风险。
Neurology. 2024 Sep 10;103(5):e209699. doi: 10.1212/WNL.0000000000209699. Epub 2024 Aug 7.
2
Assessment tools for cognitive performance in Parkinson's disease and its genetic contributors.帕金森病认知功能及其遗传因素的评估工具。
Front Neurol. 2024 Jun 26;15:1413187. doi: 10.3389/fneur.2024.1413187. eCollection 2024.
3
Cognitive heterogeneity in Parkinson's disease: A mechanistic view.帕金森病认知异质性:一种机制观点。
Neuron. 2023 May 17;111(10):1531-1546. doi: 10.1016/j.neuron.2023.03.021. Epub 2023 Apr 6.
4
Systematic review of data-driven cognitive subtypes in Parkinson disease.帕金森病数据驱动认知亚型的系统评价。
Eur J Neurol. 2022 Nov;29(11):3395-3417. doi: 10.1111/ene.15481. Epub 2022 Jul 18.
5
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches.帕金森病胆碱能系统改变:新兴治疗方法。
Lancet Neurol. 2022 Apr;21(4):381-392. doi: 10.1016/S1474-4422(21)00377-X. Epub 2022 Feb 4.
6
The Cholinergic Brain in Parkinson's Disease.帕金森病中的胆碱能脑
Mov Disord Clin Pract. 2021 Aug 23;8(7):1012-1026. doi: 10.1002/mdc3.13319. eCollection 2021 Oct.
7
Cognitive Decline in Parkinson's Disease: A Subgroup of Extreme Decliners Revealed by a Data-Driven Analysis of Longitudinal Progression.帕金森病中的认知衰退:通过对纵向进展的数据驱动分析揭示的极端衰退亚组
Front Psychol. 2021 Sep 9;12:729755. doi: 10.3389/fpsyg.2021.729755. eCollection 2021.
8
Parkinson disease-associated cognitive impairment.帕金森病相关认知障碍。
Nat Rev Dis Primers. 2021 Jul 1;7(1):47. doi: 10.1038/s41572-021-00280-3.
9
Identifying subtypes of mild cognitive impairment in Parkinson's disease using cluster analysis.采用聚类分析识别帕金森病轻度认知障碍亚型。
J Neurol. 2020 Nov;267(11):3213-3222. doi: 10.1007/s00415-020-09977-z. Epub 2020 Jun 13.
10
Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1).用临床标志物预测帕金森病患者的认知能力下降(PRECODE-1)。
J Neural Transm (Vienna). 2020 Jan;127(1):51-59. doi: 10.1007/s00702-019-02125-6. Epub 2019 Dec 18.